Free Trial

Arteris (AIP) Expected to Announce Quarterly Earnings on Tuesday

Arteris logo with Computer and Technology background

Key Points

  • Arteris is set to announce its Q2 2025 earnings on August 5, with analysts predicting a loss of ($0.11) per share and revenue of $16.35 million.
  • The company's stock has recently traded up 2.3%, reaching $9.66, with a market cap of $405.69 million and a P/E ratio of -11.85.
  • Insiders have sold a total of 122,448 shares in the last 90 days, while institutional investors now own 64.36% of the stock, indicating strong investor interest.
  • MarketBeat previews the top five stocks to own by August 1st.
  • Limited Time Offer: Unlock powerful research tools, advanced financial data, and expert insights to help you invest with confidence. Save 50% when you upgrade to MarketBeat All Access during the month of July. Claim your discount here.

Arteris (NASDAQ:AIP - Get Free Report) is expected to announce its Q2 2025 earnings results after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $16.35 million for the quarter.

Arteris Trading Down 1.4%

AIP traded down $0.15 on Wednesday, hitting $10.45. 735,178 shares of the company's stock traded hands, compared to its average volume of 384,900. The company's 50 day simple moving average is $8.80 and its 200-day simple moving average is $8.44. Arteris has a one year low of $5.46 and a one year high of $12.64. The firm has a market cap of $438.69 million, a price-to-earnings ratio of -12.74 and a beta of 1.44.

Analysts Set New Price Targets

Separately, Rosenblatt Securities reissued a "buy" rating and issued a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st.

Get Our Latest Stock Report on AIP

Insider Transactions at Arteris

In other Arteris news, CFO Nicholas B. Hawkins sold 11,000 shares of Arteris stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $7.54, for a total value of $82,940.00. Following the sale, the chief financial officer owned 165,596 shares of the company's stock, valued at $1,248,593.84. The trade was a 6.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Laurent R. Moll sold 4,704 shares of Arteris stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $8.99, for a total transaction of $42,288.96. Following the completion of the transaction, the chief operating officer directly owned 478,761 shares of the company's stock, valued at $4,304,061.39. The trade was a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 122,448 shares of company stock worth $1,127,923. 29.10% of the stock is currently owned by company insiders.

Institutional Trading of Arteris

An institutional investor recently bought a new position in Arteris stock. Strs Ohio acquired a new position in Arteris, Inc. (NASDAQ:AIP - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,100 shares of the company's stock, valued at approximately $104,000. Institutional investors own 64.36% of the company's stock.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Read More

Earnings History for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday
ACT FAST! Congress is Dumping these 3 Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines